A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease

Citations of this article
Mendeley users who have this article in their library.
Get full text


Brain-specific glutathione S-transferase Mu 3 (GSTM3) colocalizes with amyloid-β plaques in Alzheimer's disease (AD). A functional polymorphism rs7483 in GSTM3 may contribute to the decrease in GSTM3 expression in AD. The association of the rs7483 SNP with late-onset AD and mild cognitive impairment (MCI) was evaluated and the impact of a SNP background on gene expression was analyzed in blood mononuclear cells (BMC). The allelic association of the GSTM3 allele with AD was significant in women and in APOEε4-negative stratum. A significant association was also found in both MCI and AD subjects with AD family history. GSTM3 transcript levels in BMC were lower in AD than in normal elderly controls, and the presence of the risk allele was associated with further mRNA reduction. Diminished GSTM3 mRNA levels correlated with decreased minichromosome maintenance deficient 3 (MCM3) mRNA levels in a diagnostic and SNP-dependent fashion. Reduced antioxidant defense and genome maintenance associated with the GSTM3 polymorphism suggest a common hub of regulatory networks which, when impaired, may lead to AD. © 2008 Elsevier Inc. All rights reserved.




Maes, O. C., Schipper, H. M., Chong, G., Chertkow, H. M., & Wang, E. (2010). A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease. Neurobiology of Aging, 31(1), 34–45. https://doi.org/10.1016/j.neurobiolaging.2008.03.007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free